Related Experiment Videos

Monitoring and prevention of renal dysfunction in cardiac transplant recipients

AACN Clinical Issues in Critical Care Nursing
|August 1, 1992
PubMed

Insights

Cardiac transplant recipients often experience renal dysfunction due to cyclosporine. Early identification and management strategies can preserve kidney function, improving patient outcomes and quality of life.

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Cardiac transplant recipients frequently develop renal dysfunction.
  • Cyclosporine, an immunosuppressant, is a common cause of nephrotoxicity in these patients.
  • Elevated serum creatinine and other renal indicators often manifest within the first year post-transplant.

Purpose of the Study:

  • To highlight the incidence and implications of renal dysfunction in cardiac transplant recipients.
  • To discuss the role of cyclosporine in post-transplant renal impairment.
  • To outline strategies for preserving renal function in this patient population.

Main Methods:

  • Review of current literature on cyclosporine-induced nephrotoxicity in cardiac transplant recipients.
  • Analysis of common renal complications, including hypertension and gout.
  • Identification of interdisciplinary strategies for renal function preservation.

Main Results:

  • Renal dysfunction, characterized by elevated creatinine, is prevalent post-cardiac transplant.
  • Hypertension and gout are frequently associated comorbidities.
  • Proactive management strategies can mitigate cyclosporine's nephrotoxic effects.

Conclusions:

  • Preserving renal function is critical for improving the overall health and survival of cardiac transplant recipients.
  • Interprofessional collaboration is essential for implementing effective renal protection strategies.
  • Minimizing nephrotoxicity enhances long-term patient outcomes and quality of life.

Related Concept Videos